Covered recipient · General Payments record
ANDREW ROBERT BLUNDELL
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2022–2024
$3,659.27
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,407.85 | 18 |
| Travel and Lodging | $1,334.07 | 2 |
| Education | $105.16 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,961.00 | 13 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $269.23 | 3 |
| GENZYME CORPORATION | $260.13 | 2 |
| Janssen Biotech, Inc. | $223.73 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $132.99 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $109.00 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339902 | CMS |
| ABBVIE INC. | $85.97 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339904 | CMS |
| ABBVIE INC. | $38.04 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339906 | CMS |
| ABBVIE INC. | $41.14 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339908 | CMS |
| ABBVIE INC. | $585.34 | 06/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104177784 | CMS |
| ABBVIE INC. | $748.73 | 06/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104177786 | CMS |
| ABBVIE INC. | $125.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339910 | CMS |
| ABBVIE INC. | $125.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339912 | CMS |
| ABBVIE INC. | $25.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339914 | CMS |
| ABBVIE INC. | $25.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339916 | CMS |
| ABBVIE INC. | $35.20 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339918 | CMS |
| ABBVIE INC. | $12.68 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339920 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103339922 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $122.82 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118092250 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $10.17 | 01/19/2024 | Education | Undisputed | 01/23/2026 | 1118092248 | CMS |
| GENZYME CORPORATION | $138.30 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139700515 | CMS |
| GENZYME CORPORATION | $121.83 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139700591 | CMS |
| Janssen Biotech, Inc. | $128.74 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078619417 | CMS |
| Janssen Biotech, Inc. | $94.99 | 08/08/2024 | Education | Undisputed | 01/23/2026 | 1078620166 | CMS |
| Novartis Pharmaceuticals Corporation | $139.47 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086743379 | CMS |
| Novartis Pharmaceuticals Corporation | $12.50 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086743381 | CMS |
| Novartis Pharmaceuticals Corporation | $117.26 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086743383 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.